STAT November 6, 2024
Bausch + Lomb’s CEO is ‘optimistic,’ while Curie.Bio CEO says RFK Jr. is ‘scary’
With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are preparing for the shift to an administration with a complicated history.
Trump...